Are Parkinson’s Patients More Vulnerable to the Effects of Cardiovascular Risk: A Neuroimaging and Neuropsychological Study

Vascular Risk Factors and Cognition in Parkinson’s Disease

(2016) Andrea Pilotto et al.   JOURNAL OF ALZHEIMERS DISEASE

Mood Differences Among Parkinson’s Disease Patients With Mild Cognitive Impairment

(2016) Jacob D. Jones et al.   JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES

Effect of olfactory impairment and white matter hyperintensities on cognition in Parkinson's disease

(2016) Jee Hyun Ham et al.   PARKINSONISM & RELATED DISORDERS

White Matter Hyperintensities and Mild Cognitive Impairment in Parkinson's Disease

(2015) Elijah Mak et al.   JOURNAL OF NEUROIMAGING

Verbal Fluency: Language or Executive Function Measure?

(2015) Douglas M. Whiteside et al.   Applied Neuropsychology-Adult

Comparison of the Movement Disorder Society Parkinson's disease dementia criteria with neuropsychological testing

(2014) Brandon R. Barton et al.   MOVEMENT DISORDERS

Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies

(2013) David J. Irwin et al.   NATURE REVIEWS NEUROSCIENCE

White matter microstructure deteriorates across cognitive stages in Parkinson disease

(2013) T. R. Melzer et al.   NEUROLOGY

Heart Disease and Stroke Statistics—2013 Update

(2012) Alan S. Go et al.   CIRCULATION

Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines

(2012) Irene Litvan et al.   MOVEMENT DISORDERS

FreeSurfer

(2012) Bruce Fischl   NEUROIMAGE

MRI-leukoaraiosis thresholds and the phenotypic expression of dementia

(2012) C. C. Price et al.   NEUROLOGY

Health comorbidities and cognition in 1948 patients with idiopathic Parkinson's disease

(2012) J.D. Jones et al.   PARKINSONISM & RELATED DISORDERS

Montreal Cognitive Assessment

(2011) Sandra Freitas et al.   ALZHEIMER DISEASE & ASSOCIATED DISORDERS

Heterogenous mechanisms of mild cognitive impairment in Parkinson’s disease

(2011) Kurt Jellinger   JOURNAL OF NEURAL TRANSMISSION

ACCF/AHA 2011 Expert Consensus Document on Hypertension in the Elderly

(2011) Wilbert S. Aronow et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

White matter lesions in Parkinson disease

(2011) Nicolaas I. Bohnen et al.   Nature Reviews Neurology

Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline

(2011) S. Debette et al.   NEUROLOGY

Understanding verbal fluency in healthy aging, Alzheimer's disease, and Parkinson's disease.

(2011) Joan McDowd et al.   NEUROPSYCHOLOGY

Systematic review of levodopa dose equivalency reporting in Parkinson's disease

(2010) Claire L. Tomlinson et al.   MOVEMENT DISORDERS

White matter changes and diabetes predict cognitive decline in the elderly: The LADIS Study

(2010) A. Verdelho et al.   NEUROLOGY

Parkinson disease and comorbid cerebrovascular disease

(2009) Wandana Nanhoe-Mahabier et al.   Nature Reviews Neurology

White matter hyperintensities do not impact cognitive function in patients with newly diagnosed Parkinson's disease

(2009) Turi O. Dalaker et al.   NEUROIMAGE

General Cardiovascular Risk Profile for Use in Primary Care

(2008) Ralph B. D’Agostino et al.   CIRCULATION

Sympathetic modulation by levodopa reduces vascular risk factors in Parkinson disease

(2008) Giulio Scigliano et al.   PARKINSONISM & RELATED DISORDERS